Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
NCT06138496
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Clear Cell Renal Cell Carcinoma
Interventions
DRUG:
Cadonilimab Combined With Lenvatinib
Sponsor
Sun Yat-sen University